Vaxinano

About Vaxinano

Vaxinano is a clinical-stage biotech company focused on developing innovative nasal and thermostable vaccines for human and animal health. Founded in 2016, their mission is to create highly stable vaccines that provide rapid, effective, and durable immune responses against infectious diseases, including parasites, viruses, and bacteria. They aim to address unmet needs in the treatment of parasitosis and zoonosis through cutting-edge research and partnerships.

Products & Services

Thermostable Nanoparticle Vaccines:A novel vaccine delivery system designed to cross mucosal barriers and activate immune responses without adjuvants, offering high stability and loading capacity.

Veterinary and Human Vaccine Pipeline:Multiple programs targeting infectious diseases like leishmaniasis and toxoplasmosis, with successful intranasal vaccinations in over 1,000 primates showing excellent safety and efficacy.

WildVax Conservation Program:A program supporting endangered species through vaccination campaigns in 24 zoos worldwide, protecting over 2,000 animals, including 600 primates, from lethal toxoplasmosis.

Specialties

Nanomedicine Vaccine Development Thermostable Nanoparticles Nasal Vaccine Delivery Infectious Disease Protection Animal and Human Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Funding round T: - FT: Funding round	A: 6000000 MR: - FA: €6 million FAN: 6000000	D: 2024-10-29 FD: 2024-10-29	6 investors

Funding round Latest

2024-10-29

$6.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Didier Betbeder

Chief Scientific Officer

J

Jonathan Stauber

Chief Executive Officer

J

Joachim Hasenmaier

Senior healthcare executive

K

Kenny Simmen

VP, head of external innovation

L

Louis Cosyn

Investor

E

Eric Bernos

Fund Manager at Captech Santé

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Vaxinano Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised